申请人:Matsumura Akira
公开号:US20110190300A1
公开(公告)日:2011-08-04
The invention relates to amide compounds of Formula I: (I) and pharmaceutically acceptable salts, prodrugs and solvates thereof, wherein: Y is CO or SOm; Z is each optionally substituted lower alkyl, lower alkenyl, cycloalkyl, aryl, heterocyclyl, etc.; R
1
and R
2
are each independently hydrogen, halogen, cyano, optionally substituted lower alky, optionally substituted cycloalkyl, optionally substituted aryl or optionally substituted heterocyclyl etc. R
3
and R
4
are hydrogen, each optionally substituted lower alkyl, cycloalkyl, aryl or heterocyclyl etc.; X is ═O, optionally substituted lower alkyl, halogen, cyano, nitro etc., n is 0-5, m is 1 or 2 and p is 0-2. The invention is also directed to the use compounds of Formula I to treat, prevent or ameliorate a disorder responsive to the blockade of calcium channels, and particularly N-type calcium channels. Compounds of the present invention are especially useful for treating pain.
本发明涉及公式I的酰胺化合物:(I)及其药学上可接受的盐,前药和溶剂化物,其中:Y为CO或SOm;Z为每个可选取代的较低烷基,较低烯基,环烷基,芳基,杂环烷基等;R1和R2分别独立地为氢,卤素,氰基,可选取代的较低烷基,可选取代的环烷基,可选取代的芳基或可选取代的杂环烷基等。R3和R4为氢,每个可选取代的较低烷基,环烷基,芳基或杂环烷基等;X为═O,可选取代的较低烷基,卤素,氰基,硝基等,n为0-5,m为1或2,p为0-2。本发明还涉及使用公式I的化合物治疗、预防或改善对钙通道阻滞剂有反应的疾病,特别是N型钙通道。本发明的化合物特别适用于治疗疼痛。